'Not for vanity's sake': Biotech firm Renovatio focusing R&D towards therapeutic skin care By Amanda Lim 02-Jun-2022 - Last updated on 02-Jun-2022 at 01:44 GMT Email to a friend Australia-based firm Renovatio Bioscience believes skin care innovation is moving towards the development of therapeutic treatments for serious skin conditions such as eczema or psoriasis. GALLERY 'Not for vanity's sake': Biotech firm Renovatio focusing R&D towards therapeutic skin care Apiaceous opportunity: Coriander oil displays anti-ageing skin care benefits – new research How to win over… The misunderstood Generation X beauty consumer Microbiome-friendly clothes: COSMAX set to commercialise 'wearable cosmetics' with anti-ageing ingredient Terrific threesome: Sigi Skin launches first serum packed with prebiotics, probiotics and postbiotics No doubt: Estée Lauder CEO remains 'enthusiastic' about China despite growing concerns The big PCR problem: 90% of sustainable beauty packaging commitments will not be met by 2025 – expert L'Oréal's India ambitions: CEO expresses resolve to grow on the back of e-commerce acceleration COVID-19 impact: How the pandemic has changed Korean millennials, Gen Z beauty attitudes – review 'Recycling has to end': Beauty industry needs to focus on reuse and refill to tackle packaging predicament Prev 1 2 3 4 5 … 11 Next